![David Hughes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
David Hughes worked as the Chief Executive Officer at CN Bio Innovations Ltd.
from 2018 to 2022.
Prior to that, he worked at GSK Plc as a Process Engineer.
Dr. Hughes received a graduate and doctorate degree from the University of Oxford.
Anciens postes connus de David Hughes
Sociétés | Poste | Fin |
---|---|---|
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Directeur Général | 19/12/2022 |
GSK PLC | Corporate Officer/Principal | - |
Formation de David Hughes
University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GSK PLC | Health Technology |
Entreprise privées | 1 |
---|---|
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Health Technology |